Furthermore, genetic factors have a substantial impact on AD development; for instance, mutations in the amyloid precursor protein (APP) and presenilin proteins (PSEN1; PSEN2) are associated with early onset AD, whereas the apolipoprotein E (APOE-ε4) allele has been correlated with an increased risk of developing late-onset AD. Here, APOE is linked to Alzheimer disease.